WisdomTree BioRevolution Fund Rating $14.47 +1.21 (+9.10%) Closing price 08/15/2025 03:34 PM EasternExtended Trading$14.47 +0.00 (+0.01%) As of 08/15/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.63Holdings in WDNA have an aggregate rating of Moderate Buy based on 330 analyst ratings issued in the past year covering 23 companies (48.9% of the portfolio).WDNA Aggregate Price Target$14.47High Prediction$14.47Average Prediction$14.47Low Prediction$14.47Holdings in WDNA have an aggregate price target of $14.47 and a range of $14.47 to $14.47 covering 23 companies (48.9% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.34%VERVVerve Therapeutics$11.133.1036 of 5 stars2.33$14.57 30.9%93.01%NTLAIntellia Therapeutics$10.99+0.8%4.5174 of 5 stars2.58$29.05 164.4%19Analyst ForecastAnalyst Revision2.74%SANASana Biotechnology$3.33-2.9%3.3818 of 5 stars3.00$8.00 140.2%6News CoverageEarnings ReportAnalyst Revision2.73%CRSPCRISPR Therapeutics$59.73+1.5%3.353 of 5 stars2.50$71.60 19.9%162.29%NTRANatera$163.02+2.9%3.2343 of 5 stars3.06$193.19 18.5%18News CoveragePositive NewsAnalyst ForecastInsider Trade2.29%DNAGinkgo Bioworks$13.16+2.0%0.975 of 5 stars2.33$8.50 -35.4%32.25%AGIOAgios Pharmaceuticals$37.01+0.9%4.3797 of 5 stars2.75$56.33 52.2%8Insider Trade2.17%TWSTTwist Bioscience$28.12-2.5%3.9548 of 5 stars2.73$49.40 75.7%11Positive News2.17%LLYEli Lilly and Company$701.51+2.5%4.9986 of 5 stars2.71$964.88 37.5%21Trending NewsAnalyst ForecastInsider TradeOptions VolumeAnalyst Revision1.98%BEAMBeam Therapeutics$17.82+1.1%2.3272 of 5 stars3.07$48.45 171.9%14News Coverage1.97%EDITEditas Medicine$3.03+2.4%4.2778 of 5 stars2.23$5.10 68.3%13News CoverageEarnings ReportAnalyst ForecastGap Up1.91%MRNAModerna$28.02+5.0%4.3959 of 5 stars2.04$43.59 55.6%24Options Volume1.88%TXG10x Genomics$13.36+0.9%3.7426 of 5 stars2.38$13.54 1.4%13Analyst Forecast1.81%GILDGilead Sciences$118.37-0.5%4.8511 of 5 stars2.80$114.82 -3.0%25Positive NewsDividend AnnouncementAnalyst Revision1.80%RGNXREGENXBIO$8.82-2.6%4.3271 of 5 stars2.83$28.38 221.7%61.76%BNTXBioNTech$113.52+0.7%1.6219 of 5 stars2.76$135.80 19.6%17Analyst ForecastAnalyst Revision1.71%VRTXVertex Pharmaceuticals$392.79+0.6%4.9494 of 5 stars2.56$497.10 26.6%27Positive News1.66%ARCTArcturus Therapeutics$19.48+1.3%2.8846 of 5 stars3.00$50.00 156.7%7Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.58%UTHRUnited Therapeutics$313.13+0.3%4.9136 of 5 stars2.69$382.00 22.0%13Positive NewsAnalyst Forecast1.56%VCYTVeracyte$30.22+0.6%2.7409 of 5 stars2.70$40.90 35.3%10Positive News1.50%AMGNAmgen$296.47+2.1%4.6677 of 5 stars2.33$303.76 2.5%21Trending NewsAnalyst Revision1.42%CTVACorteva$71.74-0.2%4.6958 of 5 stars2.87$80.25 11.9%15News CoveragePositive NewsAnalyst Upgrade1.40%IONSIonis Pharmaceuticals$43.78+2.2%4.5624 of 5 stars2.86$59.38 35.6%14Analyst Upgrade This page (BATS:WDNA) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access